Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 2, 2008, Pages 390-395

  Abdullah, Siraj Saadaldin ^a,b   Pialat, Jean Baptiste ^a,b   Wiart, Marlene ^b   Duboeuf, François ^b   Mabrut, Jean Yves ^a   Bancel, Brigitte ^a   Rode, Agnès ^a   Ducerf, Christian ^a   Baulieux, Jacques ^a   Berthezene, Yves ^a,b  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Cancer; Liver; Microvascular; MRI; Quantification

Indexed keywords

GADOTERATE MEGLUMINE;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISTRIBUTION VOLUME; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER PARENCHYMA; LIVER PERFUSION; MALE; PERFUSION WEIGHTED IMAGING; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 49049116911     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21429     Document Type: Article

References (35)

1. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001;28:441-449.
2. Ueda K, Terada T, Nakanuma Y, Matsui O. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. Hum Pathol 1992;23:619-626.
3. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 1991;178:493-497.
4. Terayama N, Terada T, Nakanuma Y. A morphometric and immunohistochemical study on angiogenesis of human metastatic carcinomas of the liver. Hepatology 1996;24:816-819.
5. Honda H, Tajima T, Taguchi K, et al. Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant and malignant hepatic nodules. J Hepatobiliary Pancreat Surg 2000;7:245-251.
6. Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M. Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 2002;225:143-149.
7. Lin G, Lunderquist A, Hagerstrand I, Boijsen E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 1984;96:517-526.
8. Strohmeyer T, Haugeberg G, Lierse W. Angioarchitecture and blood supply of micro- and macrometastases in human livers. An anatomic-pathological investigation using injection-techniques. J Hepatol 1987;4:181-189.
9. Voboril R. Blood supply of metastatic liver tumors: an experimental study. Int Surg 2005;90:71-77.
10. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005;234:661-673.
11. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002;47:135-142.
12. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409-414.
13. Peeters F, Annet L, Hermoye L, Van Beers BE. Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med 2004;51:710-717.
14. Scharf J, Zapletal C, Hess T, et al. Assessment of hepatic perfusion in pigs by pharmacokinetic analysis of dynamic MR images. J Magn Reson Imaging 1999;9:568-572.
15. Neyran B, Janier MF, Casali C, Revel D, Canet Soulas EP. Mapping myocardial perfusion with intravascular MR contrast agent: robustness of deconvolution methods at various blood flows. Magn Reson Med 2002;48:166-179.
16. Cuenod C, Leconte I, Siauve N, et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001;218:556-561.
17. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6:731-744.
18. Biasco G, Derenzini E, Grazi G, et al. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 2006;32:214-228.
19. DeMatteo RP, Fong Y, Blumgart LH. Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 1999;13:557-574.
20. Gharbi L, Mannai S, Ghariani B, Mestiri H, Khalfallah MT. Treatment of primary and secondary malignant tumor of the liver. Opinion of the surgeon. Tunis Med 2006;84:683-686.
21. Nino-Murcia M, Olcott EW, Jeffrey RB, Lamm RL, Beaulieu CF, Jain KA. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology 2000;215:746-751.
22. Kan Z, Ivancev K, Lunderquist A, et al. In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 1993;187:621-626.
23. Terayama N, Matsui O, Ueda K, et al. Peritumoral rim enhancement of liver metastasis: hemodynamics observed on single-level dynamic CT during hepatic arteriography and histopathologic correlation. J Comput Assist Tomogr 2002;26:975-980.
24. Eichhorn ME, Strieth S, Dellian M. Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives. Drug Resist Updat 2004;7:125-138.
25. Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 2000;89:2606-2612.
26. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-693.
27. Fournier LS, Cuenod CA, de Bazelaire C, et al. Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol 2004;14:2125-2133.
28. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001;176:667-673.
29. Kojima H, Tanigawa N, Komemushi A, Kariya S, Sawada S. Computed tomography perfusion of the liver: assessment of pure portal blood flow studied with CT perfusion during superior mesenteric arterial portography. Acta Radiol 2004;45:709-715.
30. Tsushima Y, Blomley JK, Kusano S, Endo K. The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci 1999;44:1632-1638.
31. Guan S, Zhao WD, Zhou KR, Peng WJ, Mao J, Tang F. CT perfusion at early stage of hepatic diffuse disease. World J Gastroenterol 2005;11:3465-3467.
32. Totman JJ, O'Gorman RL, Kane PA, Karani JB. Comparison of the hepatic perfusion index measured with gadolinium-enhanced volumetric MRI in controls and in patients with colorectal cancer. Br J Radiol 2005;78:105-109.
33. Materne R, Van Beers BE, Smith AM, et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 2000;99:517-525.
34. Greenway CV, Stark RD. Hepatic vascular bed. Physiol Rev 1971;51:23-65.
35. Miles KA, Leggett DA, Kelley BB, Hayball MP, Sinnatamby R, Bunce I. In vivo assessment of neovascularisation of the liver metastases using perfusion CT. Br J Radiol 1998;71:276-281.